New WA trial to prevent early urinary infection in acute SCI

This trial is led by UWA, in collaboration with clinicians at Royal Perth and Fiona Stanley Hospitals. It follows the group’s recent audit of SCI bladder health (https://www.nature.com/articles/s41393-019-0337-6) which showed that early UTIs are associated with a higher rate of ongoing infections. Researchers will test the use of glycosaminoglycans, or “GAGs”, to protect against early infections. GAGs are directly introduced into the bladder via a catheter – an approach shown to be safe and effective in preventing recurrent UTIs in otherwise healthy women. The treatment has not yet been tested in acute SCI, so the trial is important to assess the safety and feasibility of providing the therapy by day 10 following injury, before UTIs have had a chance to develop. Click here to read more on this and other related research at the Investigators’ “Better Bladders” blog… http://blogs.uwa.edu.au/scibladder/